DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a global leader in sterile medication production and delivery, today announced the U.S. Food and Drug Administration (FDA) ...
Hikma's Mitomycin for Injection, USP is not recommended as single-agent, primary therapy. The company said it has been shown to be useful in the therapy of disseminated adenocarcinoma of the stomach ...
(Sharecast News) - Hikma Pharmaceuticals announced on Tuesday that its Hikma Pharmaceuticals USA division, formerly known as West-Ward Pharmaceuticals, has launched Mitomycin for Injection, USP' at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback